Aarkstore - Metastatic Breast Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 - PowerPoint PPT Presentation

View by Category
About This Presentation
Title:

Aarkstore - Metastatic Breast Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Description:

Metastatic Breast Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Metastatic Breast Cancer. Browse full report @ – PowerPoint PPT presentation

Number of Views:46

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: Aarkstore - Metastatic Breast Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015


1
Aarkstore - Metastatic Breast Cancer-Global API
Manufacturers, Marketed and Phase III Drugs
Landscape, 2015
Category Pharmaceuticals and Healthcare
2
Synopsis
  • Metastatic Breast Cancer - Global API
    Manufacturers, Marketed and Phase III Drugs
    Landscape, 2015, Report provides comprehensive
    insights about phase III pipeline drugs and
    marketed drugs across the Metastatic Breast
    Cancer. A key objective of DelveInsights report
    is to establish the understanding for API
    Manufacturers for marketed and Phase III Pipeline
    drugs across the different countries and regions
    for the drugs falling under Metastatic Breast
    Cancer. The Report gives insights into patents
    providing thepatent protection data and marketing
    exclusivity of all the drugs across the
    Metastatic Breast Cancer.

Browse Complete Report http//www.aarkstore.com
/pharmaceuticals-healthcare/98049/metastatic-breas
t-cancer-global-api-manufacturers-marketed-and-pha
se-iii-drugs-landscape-2015
3
Data Sources
  • The report is built using data and information
    sourced from proprietary databases, primary and
    secondary research and in-house analysis by
    DelveInsight team of industry experts.Secondary
    sources information and data has been collected
    from various printable and non-printable sources
    like search engines, News websites, Government
    Websites, Trade Journals, White papers,
    Magazines, Trade associations, Books, Industry
    Portals, Industry Associations and access to
    available databases.Please noteThis report
    requires certain updates. We have all the
    information available but require 3 business days
    to complete the process and ensure it is as
    up-to-date as possible. Certain sections in the
    report may be removed or altered based on the
    availability and relevance of data for the
    indicated disease. 

4
Scope 
  • A snapshot of the global Market therapeutics
    scenario for Metastatic Breast Cancer.
  • A review of the marketed products under
    prescription for Metastatic Breast Cancer,
    regulatory information and marketing status.
  • Coverage of global patent coverage and detailed
    commentaries on the US patent challenges. 
  • Graphical representation of investigational
    products for patent expiry and market
    exclusivities across the globe.
  • Product profiles for marketed products for
    Metastatic Breast Cancer with complete
    description of mechanism of action, therapeutic
    class, target, route(s) of administration and
    chemical details.
  • Coverage of API Manufacturers for Metastatic
    Breast Cancer drugs in the United States, Europe
    and Asian Regions with location details.
  • Coverage of Regulatory filings in theUS, Europe,
    and Asia specifically India and China for
    Metastatic Breast Cancer drugs.
  • Coverage of Route of Synthesis of Active
    Pharmaceutical Ingredient associated with
    Metastatic Breast Cancer drugs.

5
Reasons To Buy
  • Evaluate the marketing status and exclusivity
    details of Metastatic Breast Cancer key products
    to exploit opportunities for generic drug
    development opportunities.
  • Identify and understand important and diverse
    types of therapeutics under Phase III development
    for Metastatic Breast Cancer.
  • Design effective counter-strategies to gain
    competitive advantage by identifying the key
    patent expiry details and exclusivity with
    respect to Metastatic Breast Cancer.
  • API intelligence over marketed drugs for
    Metastatic Breast Cancer and gaining primary
    intelligence over active ingredients
    manufacturers across the globe.
  • API intelligence over leading Phase III Pipeline
    drugs.
  • Develop and design strategies by identifying the
    API manufacturers for Phase III Pipeline products
    to enhance and expand business potential and
    scope.

6
Table of Content
  • Indication Overview
  • Marketed Drugs
  • Marketed Details of Drugs by Application Type
  • Marketed Details of Drugs (NDA) by Marketing
    Status
  • Marketed Details of Drugs by Patent Expiration
    Timeline
  • Active Pharmaceutical Ingredient (API)
    Manufacturers Assessment
  • API Manufacturers by United States Drug Master
    File (US DMF) Status
  • API Manufacturers by US DMF Status (Drug
    Specific)
  • API Manufacturers in Europe by Country
  • API Manufacturers in India by State
  • API Manufacturers in China by Province

7
List of Tables
  • Metastatic Breast Cancer Therapeutic Market, US,
    Marketed Drugs by Application Type, 2015
  • Metastatic Breast Cancer Therapeutic Market, US,
    Marketed Drugs by Marketing Status, 2015
  • Metastatic Breast Cancer Therapeutic Market, US,
    (Year), 2015
  • Metastatic Breast Cancer Marketed Drugs, API
    Manufacturers by US DMF Status, 2015
  • Metastatic Breast Cancer Marketed Drugs, US DMF
    Status Drug Specific (Number), 2015
  • Metastatic Breast Cancer Drugs, API
    Manufacturers, Europe by Country, 2015
  • Metastatic Breast Cancer Drugs, API
    Manufacturers, India by State, 2015
  • Metastatic Breast Cancer Drugs, API
    Manufacturers, China by Province, 2015

8
List of Figures
  • Metastatic Breast Cancer Therapeutic Market, US,
    Marketed Drugs by Application Type (), 2015
  • Metastatic Breast Cancer Therapeutic Market, US,
    Marketed Drugs by Marketing Status (), 2015
  • Metastatic Breast Cancer Therapeutic Market, US,
    (Year), 2015
  • Metastatic Breast Cancer Marketed Drugs, API
    Manufacturers by US DMF Status (), 2015
  • Metastatic Breast Cancer Marketed Drugs, US DMF
    Status Drug Specific (Number), 2015
  • Metastatic Breast Cancer Drugs, API
    Manufacturers, Europe by Country, 2015
  • Metastatic Breast Cancer Drugs, API
    Manufacturers, India by State, 2015
  • Metastatic Breast Cancer Drugs, API
    Manufacturers, China by Province, 2015
  • Metastatic Breast Cancer Drugs, API Manufacturers
    by Geography 2015

9
Related Reports
  • Lung Cancer-Global API Manufacturers, Marketed
    and Phase III Drugs Landscape, 2015
  • Global Patient Temperature Management Market
    2015-2019
  • Global Infertility Market 2015-2019
  • Global Preventable Vaccines Market 2015-2019
  • Global Transplantation Market 2015-2019
  • Global Ultrasound Equipment Market 2015-2019
  • Cystic Fibrosis Market in Europe 2015-2019
  • Global Cell Culture Protein Surface Coating
    Market 2015-2019
  • Global Infertility Market 2015-2019
  • Generic Drugs Market in Japan 2015-2019

10
  • Metastatic Breast Cancer-Global API
    Manufacturers, Marketed and Phase III Drugs
    Landscape, 2015
  • Published Feb 2015 100 Pages
  • Metastatic Breast Cancer-Global API
    Manufacturers, Marketed and Phase III Drugs
    Landscape, 2015, Report provides comprehensive
    insights about phase III pipeline drugs and
    marketed drugs across the Metastatic Breast
    Cancer. Price

Format Price
PDF 2000
Site Licence 4000
Enterprise Wide Licence 6000
11
Contact Us
Office Office No. - 809, 8th Floor,B-Wing,
Mahaavir Icon, Plot No.- 89 90,
Sector-15,CBD-Belapur, Navi Mumbai
400614, Maharashtra, India. Telefax No 91 22
4127 6660 24/7 Online Support 91
9987295242 General Inquiries 91 - 22 2756 4953
  • You Can Visit http//www.aarkstore.com
  • OR Mail us at contact_at_aarkstore.com
  • Blog
  • http//www.aarkstore.com/blog/
  • Conference
  • http//conference.aarkstore.com/
  • News
  • http//www.aarkstore.com/news
About PowerShow.com